UroGen Pharma Ltd (URGN) insider trading
Every open-market stock purchase and sale by UroGen Pharma Ltd executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.4M over the last 12 months (7 sales). No open-market buys.
- Last insider buy: Mark Schoenberg (C-suite exec), $2.1K, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.4M (7 sales). Last close $27.25 on Jun 7, 2026.
Recent URGN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 22, 2026 | Mark Schoenberg (C-suite exec) | Sold | $350K |
| Jun 22, 2026 | Daniel George Wildman (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Cynthia M Butitta (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Daniel George Wildman (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Cynthia M Butitta (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Leana Wen (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Arie Belldegrun (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Stuart Holden (Director) | Bought (not open market) | — |
| Jun 22, 2026 | James A. Robinson Jr. (Director) | Bought (not open market) | — |
| Jun 22, 2026 | James A. Robinson Jr. (Director) | Bought (not open market) | — |
| Jun 22, 2026 | Leana Wen (Director) | Bought (not open market) | — |
| Jun 8, 2026 | Mark Schoenberg (C-suite exec) | Sold | $143K |
| Jun 8, 2026 | Mark Schoenberg (C-suite exec) | Bought (not open market) | — |
| May 26, 2026 | James A. Robinson Jr. (Director) | Bought (not open market) | — |
| May 8, 2026 | Mark Schoenberg (C-suite exec) | Sold | $300K |
| Feb 3, 2026 | Mark Schoenberg (C-suite exec) | Sold | $72.6K |
| Feb 3, 2026 | Jason Drew Smith (General Counsel) | Sold | $63.3K |
| Feb 3, 2026 | Jason Drew Smith (General Counsel) | Sold | $52.3K |
| Feb 3, 2026 | Mark Schoenberg (C-suite exec) | Sold | $36.3K |
| Feb 3, 2026 | Mark Schoenberg (C-suite exec) | Sold | $36.3K |
| Feb 3, 2026 | Jason Drew Smith (General Counsel) | Sold | $31.7K |
| Jan 31, 2026 | Jason Drew Smith (General Counsel) | Bought (not open market) | — |
| Jan 31, 2026 | Chris Degnan (CFO) | Bought (not open market) | — |
| Jan 31, 2026 | Elizabeth A. Barrett (CEO) | Bought (not open market) | — |
| Jan 31, 2026 | Mark Schoenberg (C-suite exec) | Bought (not open market) | — |
Who's trading URGN
- Cynthia M Butitta, Director: other filings, last Jun 22, 2026
- Stuart Holden, Director: other filings, last Jun 22, 2026
- James A. Robinson Jr., Director: other filings, last Jun 22, 2026
- Mark Schoenberg, C-suite exec: sold $1.2M (7 sales), last Jun 22, 2026
- Leana Wen, Director: other filings, last Jun 22, 2026
- Daniel George Wildman, Director: other filings, last Jun 22, 2026
- Arie Belldegrun, Director: other filings, last Jun 22, 2026
- Jason Drew Smith, General Counsel: sold $147K (3 sales), last Feb 3, 2026
- Elizabeth A. Barrett, CEO: other filings, last Jan 31, 2026
- Chris Degnan, CFO: sold $37.1K (1 sale), last Jan 31, 2026
Get free alerts when an insider at UroGen Pharma Ltd files a new trade →